Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, Group CS. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54:2665–73.

Article  PubMed  Google Scholar 

Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361(5):496–509. https://doi.org/10.1056/NEJMra0804595.

Sakkas LI, Bogdanos DP. Are psoriasis and psoriatic arthritis the same disease? The IL-23/IL-17 axis data. Autoimmun Rev. 2017;16:10–5.

Article  CAS  PubMed  Google Scholar 

Queiro R, Coto P. Multidisciplinary care for psoriatic disease: where we are and where we need to go. Rheumatology (Oxford). 2017;56:1829–31.

PubMed  Google Scholar 

Mahil SK, Capon F, Barker JN. Update on psoriasis immunopathogenesis and targeted immunotherapy. Semin Immunopathol. 2016;38:11–27.

Article  CAS  PubMed  Google Scholar 

Mavropoulos A, Varna A, Zafiriou E, Liaskos C, Alexiou I, Roussaki-Schulze A, Vlychou M, Katsiari C, Bogdanos DP, Sakkas LI. IL-10 producing bregs are impaired in psoriatic arthritis and psoriasis and inversely correlate with IL-17- and IFNgamma-producing T cells. Clin Immunol. 2017;184:33–41.

Article  CAS  PubMed  Google Scholar 

Di Meglio P, Villanova F, Nestle FO. Psoriasis. Volume 4. Cold Spring Harb Perspect Med. 2014;4(8). https://doi.org/10.1101/cshperspect.a015354.

Khmaladze I, Kelkka T, Guerard S, Wing K, Pizzolla A, Saxena A, Lundqvist K, Holmdahl M, Nandakumar KS, Holmdahl R. Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice. Proc Natl Acad Sci U S A. 2014;111:E3669–3678.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mesquita PM, Diogo AF, Jorge MT, Berbert AL, Mantese SA, Rodrigues JJ. Relationship of Helicobacter pylori seroprevalence with the occurrence and severity of psoriasis. Bras Dermatol. 2017;92:52–7.

Article  Google Scholar 

Fathy G, Said M, Abdel-Raheem SM, Sanad H (2010) Helicobacter Pylori Infection: A possible predisposing factor in chronic plaque-type psoriasis. J Egypt Women Dermatol Soc 7(1):39-43.

Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu JCY, et al. Global prevalence of Helicobacter pylori infection: systematic review and Meta-analysis. Gastroenterology. 2017;153:420–9.

Article  PubMed  Google Scholar 

Yong WC, Upala S, Sanguankeo A. Association between Psoriasis and Helicobacter pylori infection: a systematic review and Meta-analysis. Indian J Dermatol. 2018;63:193–200.

Article  PubMed  PubMed Central  Google Scholar 

Yu M, Zhang R, Ni P, Chen S, Duan G (2019). Helicobacter pylori Infection and Psoriasis: a systematic review and meta-analysis. Medicina (Kaunas) 55(10):645.

Zhelenova G, Tserovska YL, Mateev L, Vassileva GS. Prevalence of Helicobacter pylori seropositivity in patients with psoriasis. Probl Infect Dis. 2015;43(1):13–17

Azizzadeh M, Nejad ZV, Ghorbani R, Pahlevan D. Relationship between Helicobacter pylori infection and psoriasis. Ann Saudi Med. 2014;34:241–4.

Article  PubMed  PubMed Central  Google Scholar 

Dauden E, Cabrera MM, Onate MJ, Pajares JM, Garcia-Diez A. CagA seropositivity in Helicobacter pylori positive patients with psoriasis. J Eur Acad Dermatol Venereol. 2004;18:116–7.

Article  CAS  PubMed  Google Scholar 

Mease PJ, Antoni CE, Gladman DD, Taylor WJ. Psoriatic arthritis assessment tools in clinical trials. Ann Rheum Dis. 2005;64(Suppl 2):ii49–54.

PubMed  PubMed Central  Google Scholar 

Fredriksson T, Pettersson U. Severe psoriasis–oral therapy with a new retinoid. Dermatologica. 1978;157:238–44.

Article  CAS  PubMed  Google Scholar 

Us D, Engin D, Hascelik G. [Evaluation of Western blot methods for serologic diagnosis of Helicobacter pylori infections]. Mikrobiyol Bul. 2002;36:153–60.

PubMed  Google Scholar 

Sezikli M, Guliter S, Apan TZ, Aksoy A, Keles H, Ozkurt ZN. Frequencies of serum antibodies to Helicobacter pylori CagA and VacA in a Turkish population with various gastroduodenal diseases. Int J Clin Pract. 2006;60:1239–43.

Article  CAS  PubMed  Google Scholar 

Efthymiou G, Dardiotis E, Liaskos C, Marou E, Tsimourtou V, Scheper T, Meyer W, Daponte A, Sakkas LI, Hadjigeorgiou G, et al. Anti-hsp60 antibody responses based on Helicobacter pylori in patients with multiple sclerosis: (ir)relevance to disease pathogenesis. J Neuroimmunol. 2016;298:19–23.

Article  CAS  PubMed  Google Scholar 

Efthymiou G, Dardiotis E, Liaskos C, Marou E, Tsimourtou V, Rigopoulou EI, Scheper T, Daponte A, Meyer W, Sakkas LI, et al. Immune responses against Helicobacter pylori-specific antigens differentiate relapsing remitting from secondary progressive multiple sclerosis. Sci Rep. 2017;7:7929.

Article  PubMed  PubMed Central  Google Scholar 

Efthymiou G, Liaskos C, Simopoulou T, Marou E, Patrikiou E, Scheper T, Meyer W, Daoussis D, Sakkas LI, Bogdanos DP. Antigen-specific humoral responses against Helicobacter pylori in patients with systemic sclerosis. Immunol Res. 2020;68(1):39–47. https://doi.org/10.1007/s12026-020-09124-w. 

Heberle H, Meirelles GV, da Silva FR, Telles GP, Minghim R. InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams. BMC Bioinformatics. 2015;16:169.

Article  PubMed  PubMed Central  Google Scholar 

Arnold IC, Dehzad N, Reuter S, Martin H, Becher B, Taube C, Muller A. Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest. 2011;121:3088–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Higgins PD, Johnson LA, Luther J, Zhang M, Sauder KL, Blanco LP, Kao JY. Prior Helicobacter pylori infection ameliorates Salmonella typhimurium-induced colitis: mucosal crosstalk between stomach and distal intestine. Inflamm Bowel Dis. 2011;17:1398–408.

Article  PubMed  Google Scholar 

Cook KW, Crooks J, Hussain K, O’Brien K, Braitch M, Kareem H, Constantinescu CS, Robinson K, Gran B. Helicobacter pylori infection reduces disease severity in an experimental model of multiple sclerosis. Front Microbiol. 2015;6:52.

Article  PubMed  PubMed Central  Google Scholar 

Ali M, Whitehead M. Clearance of chronic psoriasis after eradication therapy for Helicobacter pylori infection. J Eur Acad Dermatol Venereol. 2008;22:753–4.

Article  CAS  PubMed  Google Scholar 

Onsun N, Ulusal A, Su H, Beycan O, Ozkaya IB, Senocak M. Impact of Helicobacter pylori infection on severity of psoriasis and response to treatment. Eur J Dermatol. 2012;22:117–20.

Article  PubMed  Google Scholar 

Campanati A, Ganzetti G, Martina E, Giannoni M, Gesuita R, Bendia E, Giuliodori K, Sandroni L, Offidani A. Helicobacter pylori infection in psoriasis: results of a clinical study and review of the literature. Int J Dermatol. 2015;54:e109–114.

Article  PubMed  Google Scholar 

Qayoom S, Ahmad QM. Psoriasis and Helicobacter pylori. Indian J Dermatol Venereol Leprol. 2003;69:133–4.

CAS  PubMed  Google Scholar 

Kao CY, Sheu BS, Wu JJ. Helicobacter pylori infection: an overview of bacterial virulence factors and pathogenesis. Biomed J. 2016;39:14–23.

Article  PubMed  PubMed Central  Google Scholar